Skip Nav Destination
Article navigation
Meeting Abstracts|
September 2000
Room A, 10/17/2000 2: 00 PM - 4: 00 PM (PS) Single Dose Tolerability and Pharmacokinetics of Parecoxib Sodium, a COX-2 Specific Inhibitor Following Intramuscular Administration : A-944
GD Searle & Co., Skokie, IL, United States.
Anesthesiology September 2000, Vol. 93, A–944.
Citation
Aziz Karim, Aziz Laurent, Michael Kuss, Richard Hubbard, Jiang Qian; Room A, 10/17/2000 2: 00 PM - 4: 00 PM (PS) Single Dose Tolerability and Pharmacokinetics of Parecoxib Sodium, a COX-2 Specific Inhibitor Following Intramuscular Administration : A-944. Anesthesiology 2000; 93:A–944 doi: https://doi.org/10.1097/00000542-200009001-00944
Download citation file:
Citing articles via
Most Viewed
Related Articles
Parecoxib Sodium, a Parenteral Cyclooxygenase 2 Selective Inhibitor, Improves Morphine Analgesia and Is Opioid-sparing following Total Hip Arthroplasty
Anesthesiology (April 2003)
Effects of Parecoxib, a Parenteral COX-2-specific Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Propofol
Anesthesiology (January 2002)
Efficacy and Safety of Intravenous Parecoxib Sodium in Relieving Acute Postoperative Pain following Gynecologic Laparotomy Surgery
Anesthesiology (August 2002)
Effect of Parecoxib, A Novel Intravenous Cyclooxygenase Type-2 Inhibitor, on the Postoperative Opioid Requirement and Quality of Pain Control
Anesthesiology (June 2002)
Safety and Efficacy of the Cyclooxygenase-2 Inhibitors Parecoxib and Valdecoxib after Noncardiac Surgery
Anesthesiology (March 2006)